top of page
Advancing Human Health Through Innovative Biologics Development
Our strategic focus centers on creating novel biologics to address unmet medical needs. Through rigorous scientific exploration and an advanced engineering platform, we develop molecular treatments designed to improve patient outcomes. We are committed to translating complex biological insights into transformative therapies.

Discovery
PC-102: Novel Protein Therapy
Biologic Innovation: Targeting Intracellular Health Pathways
Pre-clinical
PC-204: Therapeutic Biologic
Health Sciences: Enhancing Cellular Response Mechanisms
Phase I
PC-301: Advanced Biologic
Targeted Therapy: Precision Delivery for Human Health
Phase II
PC-507: Specialized Biologic
Therapeutic Core: Resolving Complex Disease Pathologies
Current Clinical Pipeline
Showcasing our primary research assets and therapeutic candidates currently in development to address critical global health challenges.

bottom of page